Bio/Pharma Business

September 09, 2022

Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.

September 08, 2022

Roche’s acquisition of Good Therapeutics grants them rights to the company's conditionally activated PD-1-regulated IL-2 program.

September 07, 2022

SIRIO is enhancing its strategy for small and medium nutrition brands as Lonza’s Sara Lesina joins as GM in Europe.

September 03, 2022

The flow of capital and scientific acuity irrigates this pharm system.

September 02, 2022

Novo Nordisk’s $1.1 billion acquisition of Forma Therapeutics is intended to expand its sickle cell and rare blood disorder portfolio.

September 02, 2022

Pharma loses battle to block price negotiations, but implementation faces many challenges.

September 02, 2022

While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.

August 29, 2022

Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.

August 26, 2022

ChargePoint Technology has acquired single-use container company PuroVaso.

August 24, 2022

Aerie to be purchased by Alcon after recently bringing two glaucoma drugs to market.